DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 47.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 43,831 shares of the medical instruments supplier’s stock after selling 39,986 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in DENTSPLY SIRONA were worth $1,560,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Beach Investment Counsel Inc. PA grew its stake in shares of DENTSPLY SIRONA by 1.4% in the fourth quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock worth $787,000 after acquiring an additional 306 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its stake in shares of DENTSPLY SIRONA by 5.4% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier’s stock worth $237,000 after purchasing an additional 359 shares in the last quarter. VisionPoint Advisory Group LLC grew its stake in shares of DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares in the last quarter. Teacher Retirement System of Texas grew its stake in shares of DENTSPLY SIRONA by 2.5% during the third quarter. Teacher Retirement System of Texas now owns 16,471 shares of the medical instruments supplier’s stock worth $563,000 after purchasing an additional 397 shares in the last quarter. Finally, Exchange Traded Concepts LLC grew its stake in shares of DENTSPLY SIRONA by 41.2% during the third quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after purchasing an additional 439 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $30.35 on Friday. The company has a 50-day simple moving average of $32.66 and a 200-day simple moving average of $32.80. DENTSPLY SIRONA Inc. has a one year low of $26.27 and a one year high of $43.24. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.55.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The business had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $972.61 million. During the same period in the prior year, the company earned $0.46 earnings per share. The business’s revenue was up 3.0% compared to the same quarter last year. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 EPS for the current year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.11%. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -103.22%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on XRAY shares. Barrington Research reiterated an “outperform” rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Piper Sandler boosted their target price on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a research note on Friday, January 12th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. SVB Leerink assumed coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They issued an “outperform” rating and a $42.00 price objective for the company. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, January 19th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $39.50.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.